Zuolong Wu is a partner based in the Hong Kong office of Haiwen & Partners.  He specializes in public and private M&A transactions, private equity investment, outbound investment, complex inbound investment and joint ventures.  He is also experienced in acquisition financing, debt issuance and debt restructuring.  He has experience in sectors of medical and healthcare, insurance, internet, media and technology, energy, education, real estate, automobile, logistics, agriculture and retail sale and consumer products.  He has advised on M&A transactions in Hong Kong, China, U.S. and Europe. 

Zuolong joined the Hong Kong office of Haiwen & Partners at the end of 2016.  Prior to joining Haiwen, Zuolong has practiced law for 13 years in Greater China. He worked for approximately 5 years at the Hong Kong offices of Paul, Weiss, Rifkind, Wharton & Garrison and Wilson Sonsini Goodrich & Rosati.  He worked at Freshfields Bruckhaus Deringer's Shanghai and London offices for more than 7 years.  He also worked at the Shanghai office of Shearman & Sterling. 

His experience includes:  

●  advising offerors in mandatory general offers for the control of Hong Kong listed companies and advising purchasers or their consortium in privatisation of Hong Kong listed companies; advising on notifiable transactions and connected transactions; the relevant listed companies include China Traditional Chinese Medicine (0570.HK), CPMC Holdings (0906.HK), Clarity Medical Group (1406.HK), JiaChen Holding Group (1937.HK), NVC International (2222.HK) and Meigu Technology (8349.HK);

●  advising founders and major investors on the privatization of US listed companies such as Wuxi PharmaTech, Qihoo 360, 21Vianet, Jumei, Autohome, iDreamSky, Focus Media, CNinsure and Yongye;

●  advising KKR, Morgan Stanley Private Equity Asia (MSPEA), Hillhouse Capital, PAOH, Alibaba, Tencent, Apollo, Baring Private Equity Asia, Bain Capital, TPG Capital, General Atlantic, Temasek, Goldman Sachs, FountainVest, CICC Private Equity, Boyu Capital, Sequoia China and health fund of China Life on cross-border investment;

●  advising PRC companies on outbound investment, such as Geely’s acquisition of Volvo, Tencent’s investment in California, AT&M’s attempted takeover of OM Group Inc., Orient Hontai Capital’s bid for MP & Silva, Sinochem’s bid for the business of Santoflex and Kaizhong Precision (002823. SHE)’s acquisitions in UK and Hong Kong;

●  advising borrowers such as consortiums formed by KKR, MSPEA, Boyu Capital, Sequoia, Tencent and founders in the acquisition financing for purposes of the privatization of Yageo, Yongye, Wuxi PharmaTech, Qihoo 360, iDreamSky and 21Vianet;

●  advising Minmetals Land (0230.hk) in its issuance of perpetual notes; advising Sinoenergy Corporation (600856.sh) in its issuance of USD debt notes; advising Tempus Holdings (06880. hk) in its private placement of convertible notes; advising LionRock Capital in its purchase of convertible notes issued by Sunshine Oilsands (02012. hk); advising on the debt restructuring of Xiwang Group; advising Great Wall, China Cinda, China Jianyin Investment, SITC International and  CITIC Financial Asset Management on debt restructurings;

●  advising multinational companies on foreign direct investment, including: Verisk Analytics, Johnson Controls, Honeywell, AB Inbev, Merck, Sinofi, Rolls Royce, BASF-Engelhard, Alcoa, Tesco, Solvay, Hercules, Avis, Brunswick, Degussa, Balfour Beatty, Low & Bonar, ProLogis, Cabot, Weatherford and Qiagen. 

Zuolong is a solicitor enrolled in the High Court of Hong Kong; he is licensed and admitted to practice as an attorney and counsellor at law in all the courts of the State of New York and he is licensed to practice law in the Mainland of the PRC.  

Zuolong studied laws in China, Europe and the U.S.  He has obtained a Bachelor of Law degree from the Law School of Wuhan University and Masters of Law degrees from the Law School of Fudan University, the Law Faculty of Lund University of Sweden and the Law School of Columbia University in the City of New York. 

Zuolong is a native Mandarin speaker and is fluent in English.